Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock*
Authors:
- 1 March 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 11 (2) , 213-216
Abstract
Stratification with an effective outcome biomarker could improve the design of interventional trials in pediatric septic shock. The objective of this study was to test the usefulness of chemokine (C-C motif) ligand 4 as an outcome biomarker for mortality in pediatric septic shock. A cross-sectional, observational study. Eighteen pediatric intensive care units in the United States. One hundred fifty-six pediatric patients with septic shock. Serum samples were obtained within 24 hrs of admission to the pediatric intensive care unit. Serum levels of chemokine (C-C motif) ligand 4 were measured by enzyme-linked immunosorbent assay and compared with mortality in a training set of 34 patients. These data were used to generate a cutoff value whose usefulness was evaluated through prospective application—without post hoc modification—to a larger validation set of 122 patients. On inspection of the training set data, a cutoff value of 140 pg/mL was chosen. When applied to the validation set, serum chemokine (C-C motif) ligand 4 levels >140 pg/mL yielded a sensitivity of 92% and a specificity of 40% for mortality. A serum level of ≤140 pg/mL had a negative predictive value for mortality of 98%. A serum level of chemokine (C-C motif) ligand 4 of ≤140 pg/mL, when obtained within 24 hrs of admission, predicts a very high likelihood of survival in pediatric septic shock. Exclusion of patients with a chemokine (C-C motif) ligand 4 level of ≤140 pg/mL from interventional clinical trials in pediatric septic shock could create a study population in which survival benefit from the study agent could be more readily demonstrated.Keywords
This publication has 16 references indexed in Scilit:
- Interleukin-8 as a Stratification Tool for Interventional Trials Involving Pediatric Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Cytokine and Chemokine Expression in Humans Infected with Sudan Ebola VirusThe Journal of Infectious Diseases, 2007
- Pediatric Septic Shock Treatment: New Clues from Genomic ProfilingPharmacogenomics, 2007
- Genome-Level Longitudinal Expression of Signaling Pathways and Gene Networks in Pediatric Septic ShockMolecular Medicine, 2007
- Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcomePhysiological Genomics, 2007
- Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003*Critical Care Medicine, 2007
- Low Levels of RANTES Are Associated with Mortality in Children with Cerebral MalariaThe Journal of Infectious Diseases, 2006
- Scope and epidemiology of pediatric sepsisPediatric Critical Care Medicine, 2005
- Detection of Macrophage Inflammatory Protein (MIP)‐1α and MIP‐1β during Experimental Endotoxemia and Human SepsisThe Journal of Infectious Diseases, 1999
- Decision support issues using a physiology based scoreIntensive Care Medicine, 1998